Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1
FINANCE-DM
1 other identifier
interventional
450
1 country
1
Brief Summary
The objective of this protocol is to answer the questions: 1) Are financial incentives layered upon nurse education and home telemonitoring superior to nurse education and home telemonitoring alone in improving metabolic control long term? 2) Are the effects of financial incentives on metabolic control sustained once the incentives are withdrawn? and 3) Are financial incentives efficacious within and consistent across racial/ethnic groups? This study provides a unique opportunity to address these gaps in the literature. Investigators propose a randomized controlled trial to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives; compared to an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (i.e. 18 months post randomization); and whether the intervention is differentially efficacious across racial/ethnic groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes
Started Dec 2019
Longer than P75 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2019
CompletedStudy Start
First participant enrolled
December 1, 2019
CompletedFirst Posted
Study publicly available on registry
December 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedAugust 6, 2025
August 1, 2025
5.6 years
November 26, 2019
August 4, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Glycemic control (HbA1c)
Blood specimens (10cc of blood) will be obtained by trained phlebotomists or nurse for HbA1c.
Change from baseline HbA1c at 12 months post intervention follow-ups
Resource Utilization and Cost
Previously validated questions on resource utilization will be administered. The questionnaires capture information on hospitalizations, physician/professional visits, and medications.
Change from baseline resource utilization and cost at at 12 months post-intervention follow-ups
Secondary Outcomes (5)
LDL-Cholesterol
Change from baseline cholesterol at at 12 months post intervention follow-ups
Quality of Life as measured by SF-12
Change from baseline quality of life measure at at 12 months post intervention follow-ups
Systolic and Diastolic Blood Pressure
Change from baseline blood pressure at at 12 months post intervention follow-ups
Self-Care Behavior
Change from baseline self-care at at 12 months post intervention follow-ups
Self-Care Behavior Brooks Medication Adherence Scale (BMAS)
Change from baseline self-care at at 12 months post intervention follow-ups
Study Arms (2)
FINANCE-DM Intervention
EXPERIMENTALThe FINANCE-DM intervention is comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives.
TIDES Intervention
ACTIVE COMPARATORPatients randomized to the active comparator group will be assigned the FORA 2-in-1 Telehealth System. A nurse educator will review the glucose and BP readings and use them to tailor and reinforce behavior change.
Interventions
The FINANCE-DM intervention is comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives. Patients randomized to FINANCE-DM will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. BG and BP will be measured daily and results will be uploaded to a secure server. A nurse educator will review the glucose and BP readings and use them to tailor and reinforce behavior change during weekly telephone-delivered diabetes education and skills training session. Participants will also receive financial rewards for: 1) uploading glucose measurements; 2) participating in telephone delivered educational sessions; and 3) absolute percentage drops in HbA1c from baseline at each 3-month follow-up intervals.
Patients randomized to the active comparator group will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. BG and BP will be measured daily and results will be uploaded to a secure server. A nurse educator will review the glucose and BP readings and use them to tailor and reinforce behavior change during weekly telephone-delivered diabetes education and skills training session.
Eligibility Criteria
You may qualify if:
- Age \>=21 years;
- Clinical diagnosis of T2DM and HbA1c \>=8% at the screening visit;
- Self-identified as White, AA or HA;
- Subject must be willing to use the FORA monitoring system for 12 months;
- Subjects must have access to a landline, Ethernet or cellphone for FORA data uploads for the study period; and 6) Ability to communicate in English.
You may not qualify if:
- Mental confusion on interview suggesting significant dementia;
- Participation in other diabetes clinical trials;
- Alcohol or drug abuse/dependency;
- Active psychosis or acute mental disorder; and
- Life expectancy \<18 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
State University of New York at Buffalo
Buffalo, New York, 14203, United States
Related Publications (1)
Egede LE, Walker R, Williams JS, Knapp R, Dismuke CE, Davidson T, Campbell JA. Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol. BMJ Open. 2020 Dec 22;10(12):e043760. doi: 10.1136/bmjopen-2020-043760.
PMID: 33371048BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leonard E Egede, MD, MS
State University of New York at Buffalo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor & Chair, Department of Medicine
Study Record Dates
First Submitted
November 26, 2019
First Posted
December 18, 2019
Study Start
December 1, 2019
Primary Completion
June 30, 2025
Study Completion
March 31, 2026
Last Updated
August 6, 2025
Record last verified: 2025-08